TWST241220C47500
- 2.80
- +1.65+143.48%
Twist Bioscience Newsroom
Express News | Twist Bioscience Shares Are Trading Higher After Leerink Partners Maintained Its Hold Rating on the Stock
Cautious Outlook for Twist Bioscience Amid Regulatory Changes and Competitive Pressures
Express News | Scorpion Capital- Remain Short on Twist Bioscience
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care
Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations
Twist Bioscience Price Target Lowered to $52 From $55 at Barclays
Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $52
Twist Bioscience Price Target Raised to $54.00/Share From $50.00 by Scotiabank
Scotiabank Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $54
A Quick Look at Today's Ratings for Twist Bioscience(TWST.US), With a Forecast Between $35 to $58
Express News | Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $48
Twist Bioscience Analyst Ratings
Twist Bioscience Reports Record Revenue in 2024
Cautious Outlook: Unfavorable Risk/Reward Profile for Twist Bioscience Amid Market Concerns
Twist Bioscience | 10-K: FY2024 Annual Report
12 Health Care Stocks Moving In Monday's Pre-Market Session
Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps
Twist Bioscience Corporation (TWST) Q4 2024 Earnings Call Transcript Summary
Twist Bioscience Corporation (TWST) Q4 2024 Earnings Call Transcript